A detailed history of Fortitude Advisory Group L.L.C. transactions in Immutep LTD stock. As of the latest transaction made, Fortitude Advisory Group L.L.C. holds 26,500 shares of IMMP stock, worth $49,290. This represents 0.03% of its overall portfolio holdings.

Number of Shares
26,500
Previous 12,100 119.01%
Holding current value
$49,290
Previous $19,000 147.37%
% of portfolio
0.03%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 05, 2025

BUY
$1.61 - $1.8 $23,184 - $25,920
14,400 Added 119.01%
26,500 $47,000
Q2 2025

Jul 22, 2025

SELL
$1.41 - $2.49 $8,742 - $15,438
-6,200 Reduced 33.88%
12,100 $19,000
Q1 2025

Apr 17, 2025

BUY
$1.7 - $2.21 $9,180 - $11,934
5,400 Added 41.86%
18,300 $32,000
Q4 2024

Jan 22, 2025

BUY
$1.82 - $2.36 $23,478 - $30,444
12,900 New
12,900 $27,000
Q1 2022

May 25, 2022

SELL
$2.3 - $3.61 $463,679 - $727,776
-201,600 Closed
0 $0
Q4 2021

May 20, 2022

BUY
$3.09 - $4.81 $622,944 - $969,695
201,600 New
201,600 $661,000

Others Institutions Holding IMMP

About IMMUTEP Ltd


  • Ticker IMMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,000
  • Market Cap $161M
  • Description
  • Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...
More about IMMP
Track This Portfolio

Track Fortitude Advisory Group L.L.C. Portfolio

Follow Fortitude Advisory Group L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortitude Advisory Group L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Fortitude Advisory Group L.L.C. with notifications on news.